Literature DB >> 15653293

Neural organization for recognition of grammatical and emotional facial expressions in deaf ASL signers and hearing nonsigners.

Stephen McCullough1, Karen Emmorey, Martin Sereno.   

Abstract

Recognition of emotional facial expressions is universal for all humans, but signed language users must also recognize certain non-affective facial expressions as linguistic markers. fMRI was used to investigate the neural systems underlying recognition of these functionally distinct expressions, comparing deaf ASL signers and hearing nonsigners. Within the superior temporal sulcus (STS), activation for emotional expressions was right lateralized for the hearing group and bilateral for the deaf group. In contrast, activation within STS for linguistic facial expressions was left lateralized only for signers and only when linguistic facial expressions co-occurred with verbs. Within the fusiform gyrus (FG), activation was left lateralized for ASL signers for both expression types, whereas activation was bilateral for both expression types for nonsigners. We propose that left lateralization in FG may be due to continuous analysis of local facial features during on-line sign language processing. The results indicate that function in part drives the lateralization of neural systems that process human facial expressions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653293     DOI: 10.1016/j.cogbrainres.2004.08.012

Source DB:  PubMed          Journal:  Brain Res Cogn Brain Res        ISSN: 0926-6410


  28 in total

1.  Analysis of the visual spatiotemporal properties of American Sign Language.

Authors:  Rain G Bosworth; Charles E Wright; Karen R Dobkins
Journal:  Vision Res       Date:  2019-09-23       Impact factor: 1.886

2.  Functional grouping and cortical-subcortical interactions in emotion: a meta-analysis of neuroimaging studies.

Authors:  Hedy Kober; Lisa Feldman Barrett; Josh Joseph; Eliza Bliss-Moreau; Kristen Lindquist; Tor D Wager
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

Review 3.  The bimodal bilingual brain: effects of sign language experience.

Authors:  Karen Emmorey; Stephen McCullough
Journal:  Brain Lang       Date:  2008-05-08       Impact factor: 2.381

4.  Prosodic and narrative processing in American Sign Language: an fMRI study.

Authors:  Aaron J Newman; Ted Supalla; Peter C Hauser; Elissa L Newport; Daphne Bavelier
Journal:  Neuroimage       Date:  2010-03-27       Impact factor: 6.556

5.  Neural Language Processing in Adolescent First-Language Learners: Longitudinal Case Studies in American Sign Language.

Authors:  Naja Ferjan Ramirez; Matthew K Leonard; Tristan S Davenport; Christina Torres; Eric Halgren; Rachel I Mayberry
Journal:  Cereb Cortex       Date:  2014-11-19       Impact factor: 5.357

6.  Visual context processing deficits in schizophrenia: effects of deafness and disorganization.

Authors:  Heather K Horton; Steven M Silverstein
Journal:  Schizophr Bull       Date:  2011-07       Impact factor: 9.306

7.  Auditory deprivation affects biases of visuospatial attention as measured by line bisection.

Authors:  Zaira Cattaneo; Carlotta Lega; Carlo Cecchetto; Costanza Papagno
Journal:  Exp Brain Res       Date:  2014-04-26       Impact factor: 1.972

8.  Factor structure of the BPRS in deaf people with schizophrenia: correlates to language and thought.

Authors:  Heather K Horton; Steven M Silverstein
Journal:  Cogn Neuropsychiatry       Date:  2011-04-08       Impact factor: 1.871

9.  Cortical plasticity for visuospatial processing and object recognition in deaf and hearing signers.

Authors:  Jill Weisberg; Daniel S Koo; Kelly L Crain; Guinevere F Eden
Journal:  Neuroimage       Date:  2011-12-22       Impact factor: 6.556

10.  Hand and mouth: cortical correlates of lexical processing in British Sign Language and speechreading English.

Authors:  Cheryl M Capek; Dafydd Waters; Bencie Woll; Mairéad MacSweeney; Michael J Brammer; Philip K McGuire; Anthony S David; Ruth Campbell
Journal:  J Cogn Neurosci       Date:  2008-07       Impact factor: 3.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.